ArticleScientific reports2025
Building a dynamic web calculator for individualized conditional survival estimation in brainstem ependymoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Machine learning-driven conditional survival prediction model for atypical teratoid/rhabdoid tumor.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026Article
- Personalized survival prediction in pediatric glioblastoma using a machine learning-powered web tool.Translational cancer research · 2026Article
- How survival time reshapes prognostic risk in giant cell glioblastoma.Discover oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brainstem ependymomas (EPNs) are rare and aggressive central nervous system tumors with unique anatomical challenges and poor prognosis. Traditional survival estimates offer limited clinical guidance due to their static nature. This study aimed to investigate the dynamic survival patterns of brainstem EPNs using conditional survival (CS) analysis and to develop a web-based nomogram model for individualized, real-time prognostication. Patients diagnosed with primary brainstem EPNs between 2000 and 2021 were identified from the SEER database. CS analysis was performed to assess changes in survival probability over time. Annual hazard rates were calculated to identify high-risk periods. Prognostic variables were selected using best subset regression (BSR) and least absolute shrinkage and selection operator (LASSO) methods. A CS-based nomogram was constructed using multivariable Cox regression and validated through calibration plots, ROC curves, and decision curve analysis (DCA). A risk stratification system and an interactive web calculator were also developed. A total of 697 patients were included and randomly assigned to training (n = 487) and validation (n = 210) cohorts. CS analysis showed that as patients survive longer after diagnosis, their probability of surviving additional years increases steadily. And six variables (age, sex, race, histology, surgery, and radiotherapy) were identified via the LASSO model for nomogram construction. The CS-nomogram demonstrated good calibration and acceptable discrimination, with 1-, 3-, and 5-year AUCs of 0.626, 0.649, and 0.656 in the training cohort, and 0.688, 0.692, and 0.687 in the validation cohort, respectively. DCA confirmed the clinical utility of the model. A risk classification system effectively stratified patients into high- and low-risk groups with significantly different survival outcomes. A web-based calculator was created to facilitate real-world application. This study presents a novel CS-based nomogram that dynamically predicts survival in patients with brainstem EPNs. By capturing time-dependent survival probabilities and integrating key clinical factors, the model offers a practical tool to support individualized prognosis, patient counseling, and follow-up planning in clinical practice. While it offers individualized prognostic insights, its clinical use requires further external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.